Modulation Of Ube3A-Ats Expression - EP3461895

The patent EP3461895 was granted to Baylor College OF Medicine on Jul 1, 2020. The application was originally filed on Jun 25, 2013 under application number EP18188705A. The patent is currently recorded with a legal status of "Revoked".

EP3461895

BAYLOR COLLEGE OF MEDICINE
Application Number
EP18188705A
Filing Date
Jun 25, 2013
Status
Revoked
Dec 17, 2021
Grant Date
Jul 1, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

F HOFFMANN LA ROCHEMar 26, 2021D YOUNG -

Patent Citations (84) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS19990130377-
DESCRIPTIONUS20020399998-
DESCRIPTIONUS20020419532-
DESCRIPTIONUS20070989574-
DESCRIPTIONUS20080026995-
DESCRIPTIONUS20080026998-
DESCRIPTIONUS20080056564-
DESCRIPTIONUS20080086231-
DESCRIPTIONUS20080097787-
DESCRIPTIONUS20080099844-
DESCRIPTIONUS20120583963-
DESCRIPTIONWO1998DK00393-
DESCRIPTIONWO2003US33466-
DESCRIPTIONWO2005US19219-
DESCRIPTIONUS2004171570
DESCRIPTIONUS2005130923
DESCRIPTIONUS2008039618
DESCRIPTIONUS2009012281
DESCRIPTIONUS4981957
DESCRIPTIONUS5034506
DESCRIPTIONUS5118800
DESCRIPTIONUS5166315
DESCRIPTIONUS5185444
DESCRIPTIONUS5319080
DESCRIPTIONUS5359044
DESCRIPTIONUS5393878
DESCRIPTIONUS5446137
DESCRIPTIONUS5466786
DESCRIPTIONUS5514785
DESCRIPTIONUS5519134
DESCRIPTIONUS5567811
DESCRIPTIONUS5576427
DESCRIPTIONUS5591722
DESCRIPTIONUS5597909
DESCRIPTIONUS5610300
DESCRIPTIONUS5627053
DESCRIPTIONUS5639873
DESCRIPTIONUS5646265
DESCRIPTIONUS5670633
DESCRIPTIONUS5698685
DESCRIPTIONUS5700920
DESCRIPTIONUS5792847
DESCRIPTIONUS6268490
DESCRIPTIONUS6525191
DESCRIPTIONUS6600032
DESCRIPTIONUS6670461
DESCRIPTIONUS6673661
DESCRIPTIONUS6770748
DESCRIPTIONUS6794499
DESCRIPTIONUS7034133
DESCRIPTIONUS7053207
DESCRIPTIONUS7399845
DESCRIPTIONUS7427672
DESCRIPTIONUS7547684
DESCRIPTIONUS7696345
DESCRIPTIONWO0063364
DESCRIPTIONWO0149687
DESCRIPTIONWO03004602
DESCRIPTIONWO2004106356
DESCRIPTIONWO2005021570
DESCRIPTIONWO2005121371
DESCRIPTIONWO2006047842
DESCRIPTIONWO2007134181
DESCRIPTIONWO2008101157
DESCRIPTIONWO2008150729
DESCRIPTIONWO2008154401
DESCRIPTIONWO2009006478
DESCRIPTIONWO2010036696
DESCRIPTIONWO2011139702
DESCRIPTIONWO9414226
DESCRIPTIONWO9839352
DESCRIPTIONWO9914226
OPPOSITIONUS2003087855
OPPOSITIONUS6184212
OPPOSITIONUS6300132
OPPOSITIONUS6617162
OPPOSITIONWO2004016754
OPPOSITIONWO2007087113
OPPOSITIONWO2011079261
OPPOSITIONWO2012009402
OPPOSITIONWO2012012467
OPPOSITIONWO2012064806
SEARCHWO2012012467
SEARCHWO2012064806

Non-Patent Literature (NPL) Citations (104) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALBAEK et al., J. Org. Chem., (20060000), vol. 71, pages 7731 - 7740-
DESCRIPTION- ALLSHIRE, Science, (20020000), vol. 297, pages 1818 - 1819-
DESCRIPTION- ALTMANN et al., Biochem. Soc. Trans., (19960000), vol. 24, pages 630 - 637-
DESCRIPTION- ALTMANN et al., Chimia, (19960000), vol. 50, pages 168 - 176-
DESCRIPTION- ALTMANN et al., Nucleosides Nucleotides, (19970000), vol. 16, pages 917 - 926-
DESCRIPTION- ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, page 403 410-
DESCRIPTION- Antisense Research and Applications, CRC Press, (19930000), pages 276 - 278-
DESCRIPTION- BAKER et al., J. Biol. Chem., (19970000), vol. 272, pages 11944 - 12000-
DESCRIPTION- BRAASCH et al., Chem. Biol., (20010000), vol. 8, pages 1 - 7-
DESCRIPTION- CATTANACH, B.M et al., Mamm. Genome, (19970000), vol. 8, pages 472 - 478-
DESCRIPTION- CHATTOPADHYAYA et al., J. Org. Chem., (20090000), vol. 74, pages 118 - 134-
DESCRIPTION- CHEN, M.; XU, R., BMC Neurosci., (20110000), vol. 12, page 1-
DESCRIPTION- CLARK, H.B. et al., J. Neurosci., (19970000), vol. 17, pages 7385 - 7395-
DESCRIPTION- CROOKE et al., J. Pharmacol. Exp. Ther., (19960000), vol. 277, pages 923 - 937-
DESCRIPTION- DINDOT, S.V. et al., Hum. Mol. Genet., (20080000), vol. 17, pages 111 - 118-
DESCRIPTION- ELAYADI et al., Curr. Opinion Invest. Drugs,, (20010000), vol. 2, pages 558 - 561-
DESCRIPTION- FAGHIHI et al., PLoS ONE, (20100000), vol. 5, page el3177-
DESCRIPTION- FREIER et al., Nucleic Acids Research, (19970000), vol. 25, no. 22, pages 4429 - 4443-
DESCRIPTION- FRIEDEN et al., Nucleic Acids Research, (20030000), vol. 21, pages 6365 - 6372-
DESCRIPTION- GAUTSCHI et al., J. Natl. Cancer Inst., (20010300), vol. 93, pages 463 - 471-
DESCRIPTION- "GENBANK", Database accession no. NT -026446.14-
DESCRIPTION- "GENBANK", Database accession no. NT 026446.14-
DESCRIPTION- "GENBANK", Database accession no. NT 187035.1-
DESCRIPTION- "GENBANK", Database accession no. NT_187035.1-
DESCRIPTION- "GENBANK", Database accession no. U82122-
DESCRIPTION- GU et al., Nucleosides, Nucleotides & Nucleic Acids, (20050000), vol. 24, no. 5-7, pages 993 - 998-
DESCRIPTION- GU et al., Oligonucleotides, (20030000), vol. 13, no. 6, pages 479 - 489-
DESCRIPTION- GU et al., Tetrahedron, (20040000), vol. 60, no. 9, pages 2111 - 2123-
DESCRIPTION- HALL et al., Science, vol. 297, pages 2232 - 2237-
DESCRIPTION- HAWKINS; MORRIS, Transcription, (20100000), vol. 1, pages 165 - 175-
DESCRIPTION- HORVATH et al., Tetrahedron Letters, (20070000), vol. 48, pages 3621 - 3623-
DESCRIPTION- HUANG, H.S. et al., Nature, (20120000), vol. 481, pages 185 - 189-
DESCRIPTION- JENUWEIN, Science, (20020000), vol. 297, pages 2215 - 2218-
DESCRIPTION- JIANG, Y. et al., Neuron., (19980000), vol. 21, pages 799 - 811-
DESCRIPTION- KABANOV et al., FEBS Lett., (19900000), vol. 259, pages 327 - 330-
DESCRIPTION- KOSHKIN et al., Tetrahedron, (19980000), vol. 54, pages 3607 - 3630-
DESCRIPTION- KUMAR et al., Bioorg. Med. Chem. Lett.,, (19980000), vol. 8, pages 2219 - 2222-
DESCRIPTION- LETSINGER et al., Proc. Natl. Acad. Sci. USA, (19890000), vol. 86, pages 6553 - 6556-
DESCRIPTION- LEUMANN, Bioorg. Med. Chem., (20020000), vol. 10, pages 841 - 854-
DESCRIPTION- LEUMANN, Bioorg. Med. Chem.,, (20020000), vol. 10, pages 841 - 854-
DESCRIPTION- MADHARESSI et al., Nat Biotechnol., (20120000), vol. 30, pages 453 - 459-
DESCRIPTION- MAHER; DOLNICK, Nuc. Acid. Res., (19880000), vol. 16, pages 3341 - 3358-
DESCRIPTION- MANOHARAN et al., Ann. N.Y. Acad. Sci., (19920000), vol. 660, pages 306 - 309-
DESCRIPTION- MANOHARAN et al., Bioorg. Med. Chem. Let., (19930000), vol. 3, pages 2765 - 2770-
DESCRIPTION- MANOHARAN et al., Bioorg. Med. Chem. Let., (19940000), vol. 4, pages 1053 - 1060-
DESCRIPTION- MANOHARAN et al., Nucleosides & Nucleotides, (19950000), vol. 14, pages 969 - 973-
DESCRIPTION- MANOHARAN et al., Tetrahedron Lett., (19950000), vol. 36, pages 3651 - 3654-
DESCRIPTION- MARTIN, Helv. Chim. Acta, (19950000), vol. 78, pages 486 - 504-
DESCRIPTION- MENG et al., Hum Mol Genet., (20120000), vol. 21, pages 3001 - 12-
DESCRIPTION- MILLER, B.H. et al., PloS One, (20100000), vol. 5, page e14458-
DESCRIPTION- MISHRA et al., Biochim. Biophys. Acta, (19950000), vol. 1264, pages 229 - 237-
DESCRIPTION- MORRIS et al., PLoS Genet., (20080000), vol. 4, page el000258-
DESCRIPTION- NAUWELAERTS et al., J. Am. Chem. Soc., (20070000), vol. 129, no. 30, pages 9340 - 9348-
DESCRIPTION- NAUWELAERTS et al., Nucleic Acids Research, (20050000), vol. 33, no. 8, pages 2452 - 2463-
DESCRIPTION- NJUNG'E, K.; HANDLEY, S. L., Pharmacol. Biochem. Behav., (19910000), vol. 38, pages 63 - 67-
DESCRIPTION- OBERHAUSER et al., Nucl. Acids Res., (19920000), vol. 20, pages 533 - 538-
DESCRIPTION- PAL-BHADRA et al., Science, (20040000), vol. 303, pages 669 - 672-
DESCRIPTION- RAASCH et al., Biochemistry, (20020000), vol. 41, pages 4503 - 4510-
DESCRIPTION- ROBEYNS et al., Acta Crystallographica, Section F: Structural Biology and Crystallization Communications, (20050000), vol. F61, no. 6, pages 585 - 586-
DESCRIPTION- ROBEYNS et al., J. Am. Chem. Soc., (20080000), vol. 130, no. 6, pages 1979 - 1984-
DESCRIPTION- RUM et al., Curr. Opinion Mol. Ther., (20010000), vol. 3, pages 239 - 243-
DESCRIPTION- SAHOO, T. et al., Nat. Genet., (20080000), vol. 40, pages 719 - 21-
DESCRIPTION- SAISON-BEHMOARAS et al., EMBO J., (19910000), vol. 10, pages 1111 - 1118-
DESCRIPTION- SHEA et al., Acids Res., (19900000), vol. 18, pages 3777 - 3783-
DESCRIPTION- SINGH et al., Chem. Commun., (19980000), vol. 4, pages 455 - 456-
DESCRIPTION- SINGH et al., J. Org. Chem., (19980000), vol. 63, pages 10035 - 10039-
DESCRIPTION- SMITH; WATERMAN, Adv. Appl. Math., (19810000), vol. 2, page 482 489-
DESCRIPTION- SRIVASTAVA et al., J. Am. Chem. Soc., (20070000), vol. 129, no. 26, pages 8362 - 8379-
DESCRIPTION- SVINARCHUK et al., Biochimie, (19930000), vol. 75, pages 49 - 54-
DESCRIPTION- TSAI, T. et al., Hum. Mol. Genet., (19990000), vol. 8, pages 1357 - 64-
DESCRIPTION- VERBEURE et al., Nucleic Acids Research, (20010000), vol. 29, no. 24, pages 4941 - 4947-
DESCRIPTION- VERDEL et al., Science, vol. 303, pages 672 - 676-
DESCRIPTION- VOLPE et al., Science, (20020000), vol. 297, pages 1833 - 1837-
DESCRIPTION- WAHLESTEDT et al., Proc. Natl. Acad. Sci. U. S. A., (20000000), vol. 97, pages 5633 - 5638-
DESCRIPTION- WANG et al., J. Am. Chem., (20000000), vol. 122, pages 8595 - 8602-
DESCRIPTION- WANG et al., J. Org. Chem., (20010000), vol. 66, pages 8478 - 82-
DESCRIPTION- WANG et al., J. Org. Chem., (20030000), vol. 68, pages 4499 - 4505-
DESCRIPTION- WANG et al., Nucleosides, Nucleotides & Nucleic Acids,, (20010000), vol. 20, no. 4-7, pages 785 - 788-
DESCRIPTION- WILLIAMS, C.A. et al., Genet. Med., (20100000), vol. 12, pages 385 - 395-
DESCRIPTION- WOOLF et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 7305 - 7309-
DESCRIPTION- ZHANG; MADDEN, Genome Res., (19970000), vol. 7, page 649 656-
OPPOSITION- "Basic Principles of Antisense Technology", CROOKE, S.T., Antisense Drug Technology: Principles, Strategies and Applications, Marcel Dekker, (20010000), pages 1 - 18, XP055794233-
OPPOSITION- "Chapter 5: Methods of Selecting Sites in RNA for Antisense Targeting", FREIER, S.M., Crooke, S.T., Antisense Drug Technology: Principles, Strategies and Applications, Marcel Dekker, (20010000), pages 107 - 119, XP001538820-
OPPOSITION- "Chapter 6: The Medicinal Chemistry of Oligonucleotides", SWAYZE, E. et al., Antisense Drug Technology: Principles, Strategies and Applications. 2nd ed., CRC Press, (20080000), pages 143 - 182, XP055467260-
OPPOSITION- KOCH, T. et al., "Quantum Mechanical Studies of DNA and LNA", Nucleic Acid Therapeutics, (20140101), vol. 24, no. 2, pages 139 - 148, XP055366884-
OPPOSITION- "SNORD109B small nucleolar RNA, C/D box 109B [ Homo sapiens (human) ]", Gene, (20200329), Database accession no. 338429, URL: ncbi, XP055794228-
OPPOSITION- WAHLESTEDT, C., "Natural antisense and noncoding RNA transcripts as potential drug targets", Drug Discovery Today, (20060601), vol. 11, no. 11-12, pages 503 - 508, XP027889295-
OPPOSITION- LUO, W. et al., "A Ribonucleolytic Rat Torpedoes RNA Polymerase II", Cell, (20041229), vol. 119, no. 7, pages 911 - 914, XP002540641
OPPOSITION- HAGEDORN, P. et al., "Locked nucleic acid: modality, diversity, and drug discovery", Drug Discovery Today, (20180101), vol. 23, no. 1, pages 101 - 114, XP055461215
OPPOSITION- PAPARGYRI, N., "Chemical Diversity of Locked Nucleic Acid-Modified Antisense Oligonucleotides Allows Optimization of Pharmaceutical Properties", Molecular Therapy: Nucleic Acids, (20200319), vol. 19, page 706, XP055794223
OPPOSITION- HUANG, H-S. et al., "Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons", Nature, (20121221), vol. 481, no. 7380, pages 185 - 189, XP055266025
OPPOSITION- BEAUDET, A., "Drugs to awaken a paternal gene", Nature, (20120000), vol. 481, no. 7380, pages 150 - 152, XP055592443
OPPOSITION- MODARRESI, F. et al., "Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation", Nature Biotechnology, (20120101), vol. 30, no. 5, pages 453 - 459, XP055223194
OPPOSITION- ROUGEULLE, C. et al., "An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript", Nature Genetics, (19980500), vol. 19, no. 1, pages 15 - 16, XP055592429
OPPOSITION- FAGHIHI, M. et al., "Regulatory roles of natural antisense transcripts", Nat Rev Mol Cell Biol, (20090901), vol. 10, no. 9, pages 637 - 643, XP055152670
OPPOSITION- DANCKWARDT, S. et al., "Focus Quality Control 3' end mRNA processing: molecular mechanisms and implications for health and disease", The EMBO Journal, (200800206), vol. 27, no. 3, pages 482 - 498, XP055592476
OPPOSITION- MENG, L . et al., "Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a", Hum Mol, (20120701), vol. 21, no. 13, pages 3001 - 3012, XP055266008
OPPOSITION- EFTHYMIOU, A. et al., "Functional Screening Assays with Neurons Generated from Pluripotent Stem Cell-Derived Neural Stem Cells", J Biomol Screen, (20130909), vol. 19, no. 1, pages 32 - 43, XP055340253
OPPOSITION- MORRIS, K. et al., "Bidirectional Transcription Directs Both Transcriptional Gene Activation and Suppression in Human Cells", PLoS Genetics, (20081101), vol. 4, no. 11, page e1000258, XP055008804
OPPOSITION- FAGHIHI, M., "RNAi Screen Indicates Widespread Biological Function for Human Natural Antisense Transcripts", PLoS One, (20101000), vol. 5, no. 10, page e13177, XP055592454
OPPOSITION- CHAMBERLAIN, S. et al., "Angelman Syndrome, a Genomic Imprinting Disorder of the Brain", The Journal of Neuroscience, (20100728), vol. 30, no. 30, pages 9958 - 9963, XP055592458
SEARCH- HSIEN-SUNG HUANG ET AL, "Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons", NATURE, London, (20111221), vol. 481, no. 7380, doi:10.1038/nature10726, ISSN 0028-0836, pages 185 - 189, XP055266025 [Y] 4-15 * the whole document *
SEARCH- LINYAN MENG ET AL, "Towards a therapy for Angelman syndrome by targeting a long non-coding RNA", NATURE, London, (20141201), vol. 518, no. 7539, doi:10.1038/nature13975, ISSN 0028-0836, pages 409 - 412, XP055556384 [T] * the whole document *
SEARCH- L. MENG ET AL, "Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a", HUMAN MOLECULAR GENETICS, gb, (20120405), vol. 21, no. 13, doi:10.1093/hmg/dds130, ISSN 0964-6906, pages 3001 - 3012, XP055266008 [Y] 4-15 * page 1009, column left - page 1010, column left *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents